[
  {
    "title": "浙江医药2022年前三季度净利4.84亿同比下滑35.46% 新药研发投入增加",
    "href": "http://stock.jrj.com.cn/2022/10/26221237087587.shtml",
    "datetime": "2022-10-26 22:12:04",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)半年度净利润3.91亿元、同比下降23.06%",
    "href": "http://stock.jrj.com.cn/2022/08/25173736936201.shtml",
    "datetime": "2022-08-25 17:37:32",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：盐酸莫西沙星氯化钠注射液获批上市",
    "href": "http://stock.jrj.com.cn/2022/08/17154236907967.shtml",
    "datetime": "2022-08-17 15:42:23",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：盐酸环丙沙星片(0.25g)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/08/03170436867103.shtml",
    "datetime": "2022-08-03 17:04:00",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：ARX305获批在晚期肿瘤患者中开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/07/12154736803321.shtml",
    "datetime": "2022-07-12 15:47:28",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：新码生物B轮增资拟引进战略投资者",
    "href": "http://stock.jrj.com.cn/2022/07/05154336783537.shtml",
    "datetime": "2022-07-05 15:43:23",
    "code": "600216"
  },
  {
    "title": "浙江医药：子公司新码生物B轮增资引进战略投资者",
    "href": "http://stock.jrj.com.cn/2022/07/05154236783483.shtml",
    "datetime": "2022-07-05 15:42:42",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：2021年度权益分派10派3.3元 股权登记日为7月5日",
    "href": "http://stock.jrj.com.cn/2022/06/27182536762003.shtml",
    "datetime": "2022-06-27 18:25:24",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：盐酸环丙沙星片获英国药品和健康产品管理局(MHRA)上市许可",
    "href": "http://stock.jrj.com.cn/2022/06/06163736705835.shtml",
    "datetime": "2022-06-06 16:37:20",
    "code": "600216"
  },
  {
    "title": "浙江医药：左氧氟沙星片收到英国药品和健康产品管理局上市许可",
    "href": "http://stock.jrj.com.cn/2022/06/01130836696373.shtml",
    "datetime": "2022-06-01 13:08:54",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：左氧氟沙星片获得英国药品和健康产品管理局上市许可",
    "href": "http://stock.jrj.com.cn/2022/05/31173136693659.shtml",
    "datetime": "2022-05-31 17:31:23",
    "code": "600216"
  },
  {
    "title": "浙江医药2022年第一季度净利2.61亿同比下滑2.37% 原材料价格上涨",
    "href": "http://stock.jrj.com.cn/2022/05/04113236554311.shtml",
    "datetime": "2022-05-04 11:32:43",
    "code": "600216"
  },
  {
    "title": "浙江医药2021年净利10.45亿同比增长45.71% 董事长李春波薪酬226.85万",
    "href": "http://stock.jrj.com.cn/2022/04/26221336479025.shtml",
    "datetime": "2022-04-26 22:13:00",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：一季度净利润降2.37%至2.61亿元",
    "href": "http://stock.jrj.com.cn/2022/04/26175436476909.shtml",
    "datetime": "2022-04-26 17:54:17",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：2021年净利增45.71%至10.45亿元 拟10派3.3元",
    "href": "http://stock.jrj.com.cn/2022/04/26175236476916.shtml",
    "datetime": "2022-04-26 17:52:24",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：抗HER2-ADC获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/04/22155236428616.shtml",
    "datetime": "2022-04-22 15:52:13",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：利奈唑胺葡萄糖注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/04/12170236315806.shtml",
    "datetime": "2022-04-12 17:02:34",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：向495名激励对象授予682.75万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/02/15171634354232.shtml",
    "datetime": "2022-02-15 17:16:14",
    "code": "600216"
  },
  {
    "title": "浙江医药2021年预计净利9.59亿-11.42亿同比增长34%-59% 持续推进降本增效",
    "href": "http://stock.jrj.com.cn/2022/01/26185134224504.shtml",
    "datetime": "2022-01-26 18:51:43",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：2021年度净利预增33.68%-59.19%",
    "href": "http://stock.jrj.com.cn/2022/01/26161334223319.shtml",
    "datetime": "2022-01-26 16:13:13",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：下属生产企业新昌制药厂通过英国远程符合性检查",
    "href": "http://stock.jrj.com.cn/2022/01/11164334146331.shtml",
    "datetime": "2022-01-11 16:43:06",
    "code": "600216"
  },
  {
    "title": "浙江医药子公司投资年产60万瓶重组人源化抗HER2单抗-AS269偶联制剂产业化项目总投资6.2亿",
    "href": "http://stock.jrj.com.cn/2021/12/30225034088687.shtml",
    "datetime": "2021-12-30 22:50:51",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟投建年产60万瓶重组人源化抗HER2单抗-AS269偶联制剂产业化项目",
    "href": "http://stock.jrj.com.cn/2021/12/30184934087744.shtml",
    "datetime": "2021-12-30 18:49:26",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟投建重组人源化抗HER2单抗-AS269偶联制剂产业化项目",
    "href": "http://stock.jrj.com.cn/2021/12/30184634087689.shtml",
    "datetime": "2021-12-30 18:46:47",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：子公司拟投建新码生物年产60万瓶重组人源化抗HER2单抗-AS269偶联制剂产业化项目",
    "href": "http://stock.jrj.com.cn/2021/12/30182234087618.shtml",
    "datetime": "2021-12-30 18:22:12",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：拟推第二期限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/12/30181434087595.shtml",
    "datetime": "2021-12-30 18:14:51",
    "code": "600216"
  },
  {
    "title": "浙江医药：ARX305获得药物临床试验申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/12/22170934047782.shtml",
    "datetime": "2021-12-22 17:09:05",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：ARX305获得药物临床试验申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/12/22170634047773.shtml",
    "datetime": "2021-12-22 17:06:14",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：苹果酸奈诺沙星氯化钠注射液、苹果酸奈诺沙星胶囊两款产品进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03161833960274.shtml",
    "datetime": "2021-12-03 16:18:23",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)第三季度净利润2.43亿元 同比增长25.58%",
    "href": "http://stock.jrj.com.cn/2021/10/25155633747273.shtml",
    "datetime": "2021-10-25 15:56:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利同比增长19% 主导产品维生素E、维生素A价格上涨",
    "href": "http://stock.jrj.com.cn/2021/08/25171233317169.shtml",
    "datetime": "2021-08-25 17:12:15",
    "code": "600216"
  },
  {
    "title": "浙江医药2021年半年度净利5.08亿元 同比净利增加18.87%",
    "href": "http://stock.jrj.com.cn/2021/08/25162733316730.shtml",
    "datetime": "2021-08-25 16:27:28",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：上半年净利增18.87%至5.08亿元",
    "href": "http://stock.jrj.com.cn/2021/08/25160433316532.shtml",
    "datetime": "2021-08-25 16:04:26",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)一度触及涨停 原董事马文鑫提前终止减持计划 未实施减持",
    "href": "http://stock.jrj.com.cn/2021/07/26094733150858.shtml",
    "datetime": "2021-07-26 09:47:19",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：原董事马文鑫提前减持计划 未实施减持",
    "href": "http://stock.jrj.com.cn/2021/07/23160033140426.shtml",
    "datetime": "2021-07-23 16:00:41",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)2020年度权益分派10派2.3元 股权登记日为7月15日",
    "href": "http://stock.jrj.com.cn/2021/07/11162933075512.shtml",
    "datetime": "2021-07-11 16:29:07",
    "code": "600216"
  },
  {
    "title": "浙江医药中标第五批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/invest/2021/06/28092033008905.shtml",
    "datetime": "2021-06-28 09:20:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：公司产品中标第五批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2021/06/27182533002944.shtml",
    "datetime": "2021-06-27 18:25:30",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：两款产品中标第五批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2021/06/27175533002897.shtml",
    "datetime": "2021-06-27 17:55:50",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：苹果酸奈诺沙星氯化钠注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/06/21171732970222.shtml",
    "datetime": "2021-06-21 17:17:09",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：左氧氟沙星氯化钠注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/06/21171432970174.shtml",
    "datetime": "2021-06-21 17:14:50",
    "code": "600216"
  },
  {
    "title": "浙江医药：MAP项目 预计年产能2.4吨",
    "href": "http://stock.jrj.com.cn/2021/06/08204432895579.shtml",
    "datetime": "2021-06-08 20:44:53",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：左氧氟沙星片获药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/05/18173532776865.shtml",
    "datetime": "2021-05-18 17:35:13",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：“抗HER2-ADC”纳入拟突破性治疗品种公示",
    "href": "http://stock.jrj.com.cn/2021/05/18173332776853.shtml",
    "datetime": "2021-05-18 17:33:17",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216)公布2021年一季报 营业收入同比增长五成",
    "href": "http://stock.jrj.com.cn/2021/04/23142132429938.shtml",
    "datetime": "2021-04-23 14:21:29",
    "code": "600216"
  },
  {
    "title": "浙江医药2020年净利增长109.29% 董事长李春波薪酬141.28万",
    "href": "http://stock.jrj.com.cn/2021/04/23093132428442.shtml",
    "datetime": "2021-04-23 09:31:34",
    "code": "600216"
  },
  {
    "title": "浙江医药2021年第一季度净利增长79.78% 主导产品VE、VA销售增长",
    "href": "http://stock.jrj.com.cn/2021/04/23092232428323.shtml",
    "datetime": "2021-04-23 09:22:11",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)2020年净利升109.29%至7.17亿元 拟10派2.3元",
    "href": "http://stock.jrj.com.cn/2021/04/22181232424681.shtml",
    "datetime": "2021-04-22 18:12:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：公司生产十一酸睾酮胶囊 目前供应紧张",
    "href": "http://stock.jrj.com.cn/2021/04/16180432387722.shtml",
    "datetime": "2021-04-16 18:04:03",
    "code": "600216"
  },
  {
    "title": "浙江医药：公司按照销售额的7―11%向太景公司支付权益金",
    "href": "http://stock.jrj.com.cn/2021/04/06084532317179.shtml",
    "datetime": "2021-04-06 08:45:48",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：新码生物拟引进战略投资者增资4.15亿元",
    "href": "http://stock.jrj.com.cn/2021/03/18154532157069.shtml",
    "datetime": "2021-03-18 15:45:06",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：注射用替考拉宁通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/17160732151258.shtml",
    "datetime": "2021-03-17 16:07:57",
    "code": "600216"
  },
  {
    "title": "浙江医药：子公司昌海制药通过美国FDA现场检查",
    "href": "http://stock.jrj.com.cn/2021/02/17141931972799.shtml",
    "datetime": "2021-02-17 14:19:04",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：子公司昌海制药通过美国FDA现场检查",
    "href": "http://stock.jrj.com.cn/2021/02/17141331972795.shtml",
    "datetime": "2021-02-17 14:13:29",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：诺氟沙星片预中标第四批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2021/02/04162331849033.shtml",
    "datetime": "2021-02-04 16:23:42",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)获高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/01/20163931729511.shtml",
    "datetime": "2021-01-20 16:39:22",
    "code": "600216"
  },
  {
    "title": "浙江医药2020年预计净利6.97亿-7.63亿增长103.28%-122.53% 整体营运成本下降",
    "href": "http://stock.jrj.com.cn/2021/01/18205231717166.shtml",
    "datetime": "2021-01-18 20:52:19",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：2020年度净利预增103.28%-122.53%",
    "href": "http://stock.jrj.com.cn/2021/01/18181031716358.shtml",
    "datetime": "2021-01-18 18:10:24",
    "code": "600216"
  },
  {
    "title": "浙江医药前三季度净利6.21亿增长72.3% 投资收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/23091231113884.shtml",
    "datetime": "2020-10-23 09:12:14",
    "code": "600216"
  },
  {
    "title": "浙江医药：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/23001031111855.shtml",
    "datetime": "2020-10-23 00:10:45",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届十三次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/23001031111854.shtml",
    "datetime": "2020-10-23 00:10:44",
    "code": "600216"
  },
  {
    "title": "[浙江医药]弘扬传统文化 交流太极传承",
    "href": "http://stock.jrj.com.cn/2020/10/23000031196647.shtml",
    "datetime": "2020-10-23 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/22232031111667.shtml",
    "datetime": "2020-10-22 23:20:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟引入新浩瑞医药 将全资子公司来益生物注册资本增加至1亿元",
    "href": "http://stock.jrj.com.cn/2020/10/22184031110013.shtml",
    "datetime": "2020-10-22 18:40:02",
    "code": "600216"
  },
  {
    "title": "浙江医药(600216.SH)：拟通过债转股形式认缴来益生物850万元注册资本",
    "href": "http://stock.jrj.com.cn/2020/10/22180931109878.shtml",
    "datetime": "2020-10-22 18:09:22",
    "code": "600216"
  },
  {
    "title": "浙江医药：公司ADC项目的II/III期临床正在按计划正常进行中",
    "href": "http://stock.jrj.com.cn/2020/10/21103631098836.shtml",
    "datetime": "2020-10-21 10:36:32",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药股份有限公司昌海生物分公司生命营养品厂项目一期 环境影响评价公示",
    "href": "http://stock.jrj.com.cn/2020/10/15000031108859.shtml",
    "datetime": "2020-10-15 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药股份有限公司昌海生物分公司镁盐回收利用技改项目 环境影响评价公示",
    "href": "http://stock.jrj.com.cn/2020/10/15000031108860.shtml",
    "datetime": "2020-10-15 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]大唐绍兴江滨热电与浙江医药产业园共办迎国庆篮球友谊赛",
    "href": "http://stock.jrj.com.cn/2020/09/27000031082394.shtml",
    "datetime": "2020-09-27 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]享美食,话中秋——新昌制药中秋活动",
    "href": "http://stock.jrj.com.cn/2020/09/26000031082398.shtml",
    "datetime": "2020-09-26 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]昌海生物质管部质量文化趣味竞技赛活动圆满成功",
    "href": "http://stock.jrj.com.cn/2020/09/10000030808738.shtml",
    "datetime": "2020-09-10 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“急性冠脉综合征”大讲堂顺利开展",
    "href": "http://stock.jrj.com.cn/2020/09/09000030808735.shtml",
    "datetime": "2020-09-09 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂研究院原料药研发课题组被认定为 绍兴市“科技先锋岗”",
    "href": "http://stock.jrj.com.cn/2020/09/08000030702815.shtml",
    "datetime": "2020-09-08 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂团委组织2020年新进大学生见面会",
    "href": "http://stock.jrj.com.cn/2020/09/04000030728853.shtml",
    "datetime": "2020-09-04 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]绍兴市2020年全民健康生活方式宣传月启动仪式顺利召开",
    "href": "http://stock.jrj.com.cn/2020/09/01000030691871.shtml",
    "datetime": "2020-09-01 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]台湾青年企业家一行来访浙江医药昌海生物产业园",
    "href": "http://stock.jrj.com.cn/2020/08/28000030691870.shtml",
    "datetime": "2020-08-28 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：子公司创新生物出口制剂已重新提交美国FDA现场审计申请",
    "href": "http://stock.jrj.com.cn/2020/08/27150030604252.shtml",
    "datetime": "2020-08-27 15:00:49",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药召开第八届十二次董事会、第八届九次监事会",
    "href": "http://stock.jrj.com.cn/2020/08/26000030704321.shtml",
    "datetime": "2020-08-26 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]民族大团结运动会之板鞋竞速比赛圆满结束",
    "href": "http://stock.jrj.com.cn/2020/08/26000030808733.shtml",
    "datetime": "2020-08-26 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/25205030587787.shtml",
    "datetime": "2020-08-25 20:50:01",
    "code": "600216"
  },
  {
    "title": "浙江医药2020年上半年净利4.27亿增长52.06% 维生素E、维生素A市场价格上涨",
    "href": "http://stock.jrj.com.cn/2020/08/25195930587570.shtml",
    "datetime": "2020-08-25 19:59:03",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药团委组织开展视频学习活动",
    "href": "http://stock.jrj.com.cn/2020/08/25000030660137.shtml",
    "datetime": "2020-08-25 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]生命营养品厂2718车间消防技能比拼活动顺利开展",
    "href": "http://stock.jrj.com.cn/2020/08/25000030808734.shtml",
    "datetime": "2020-08-25 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]省人大李学忠副主任来新开展土壤污染防治法执法检查",
    "href": "http://stock.jrj.com.cn/2020/08/20000030660138.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江昌海制药有限公司年产100吨乳酸左氧氟沙星、年产50吨苹果酸奈诺沙星技改项目环评公示",
    "href": "http://stock.jrj.com.cn/2020/08/20000030569711.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂变电岗位技能比武简讯",
    "href": "http://stock.jrj.com.cn/2020/08/19000030691867.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]热火朝天 排球场上显身手 —— 县职工气排球比赛报道",
    "href": "http://stock.jrj.com.cn/2020/08/19000030691868.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]生命在于运动,篮球让民族更团结",
    "href": "http://stock.jrj.com.cn/2020/08/18000030808736.shtml",
    "datetime": "2020-08-18 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“校企联谊,紧密无间” 浙江财经大学教职员工与浙江医药 羽毛球队友谊赛",
    "href": "http://stock.jrj.com.cn/2020/08/12000030691866.shtml",
    "datetime": "2020-08-12 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]越城区总工会领导来昌海生物产业园进行高温慰问",
    "href": "http://stock.jrj.com.cn/2020/08/12000030808737.shtml",
    "datetime": "2020-08-12 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药产业园第六届钓鱼比赛顺利结束",
    "href": "http://stock.jrj.com.cn/2020/08/02000030808739.shtml",
    "datetime": "2020-08-02 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药新昌制药厂再获省科技进步一等奖",
    "href": "http://stock.jrj.com.cn/2020/07/24000030331855.shtml",
    "datetime": "2020-07-24 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药股东马文鑫减持10万股 套现约201.8万元",
    "href": "http://stock.jrj.com.cn/2020/06/22190729990283.shtml",
    "datetime": "2020-06-22 19:07:34",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/18221029959756.shtml",
    "datetime": "2020-06-18 22:10:09",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/06/05232029856009.shtml",
    "datetime": "2020-06-05 23:20:03",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌县科技创新大会 沈大冬团队获企业自主创新优秀团队",
    "href": "http://stock.jrj.com.cn/2020/06/01000029875930.shtml",
    "datetime": "2020-06-01 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药股东王红卫减持3.75万股 套现约66.19万元",
    "href": "http://stock.jrj.com.cn/2020/05/13212329663765.shtml",
    "datetime": "2020-05-13 21:23:13",
    "code": "600216"
  },
  {
    "title": "浙江医药全资子公司拟投资建设浙江可明生物医药一期项目 预计总投资约16.42亿元",
    "href": "http://stock.jrj.com.cn/2020/04/26212529378879.shtml",
    "datetime": "2020-04-26 21:25:43",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟投资可明生物一期项目 布局大健康产业",
    "href": "http://stock.jrj.com.cn/2020/04/24224429370167.shtml",
    "datetime": "2020-04-24 22:44:33",
    "code": "600216"
  },
  {
    "title": "浙江医药2019年净利3.43亿较上年同期减少5.97% 加大研发投入",
    "href": "http://stock.jrj.com.cn/2020/04/24113729365803.shtml",
    "datetime": "2020-04-24 11:37:58",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届十次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/24005029361926.shtml",
    "datetime": "2020-04-24 00:50:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/24005029361927.shtml",
    "datetime": "2020-04-24 00:50:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/24004029361895.shtml",
    "datetime": "2020-04-24 00:40:17",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/24004029361894.shtml",
    "datetime": "2020-04-24 00:40:17",
    "code": "600216"
  },
  {
    "title": "[浙江医药]公司八届十次董事会、八届七次监事会顺利召开",
    "href": "http://stock.jrj.com.cn/2020/04/24000029852462.shtml",
    "datetime": "2020-04-24 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年净利同比减少5.97％ 拟10派10元",
    "href": "http://stock.jrj.com.cn/2020/04/23191229360028.shtml",
    "datetime": "2020-04-23 19:12:43",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂翟德伟主任带领的合成技术中心被认定为绍兴市“科技先锋岗”",
    "href": "http://stock.jrj.com.cn/2020/04/13000029852464.shtml",
    "datetime": "2020-04-13 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药2名股东拟减持股份 预计合计减持不超总股本0.01%",
    "href": "http://stock.jrj.com.cn/2020/03/24204729097046.shtml",
    "datetime": "2020-03-24 20:47:59",
    "code": "600216"
  },
  {
    "title": "[浙江医药]中国证监会投资者保护局温馨提示",
    "href": "http://stock.jrj.com.cn/2020/02/28000029852460.shtml",
    "datetime": "2020-02-28 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：国内首家通过诺氟沙星片仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/02/06164628784573.shtml",
    "datetime": "2020-02-06 16:46:30",
    "code": "600216"
  },
  {
    "title": "浙江医药：诺氟沙星片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/02/06161828784436.shtml",
    "datetime": "2020-02-06 16:18:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：合计捐赠价值510万元药品和100万元善款",
    "href": "http://stock.jrj.com.cn/2020/02/02223228749576.shtml",
    "datetime": "2020-02-02 22:32:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：再次捐赠310万元药品抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/01/28172128739517.shtml",
    "datetime": "2020-01-28 17:21:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药已捐赠第二批310万元药品抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/01/28000029852456.shtml",
    "datetime": "2020-01-28 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]抗击疫情 浙江医药在行动",
    "href": "http://stock.jrj.com.cn/2020/01/24000029852461.shtml",
    "datetime": "2020-01-24 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药新昌制药厂再获国家科技进步二等奖",
    "href": "http://stock.jrj.com.cn/2020/01/14000029852468.shtml",
    "datetime": "2020-01-14 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药一项目在中国药科大学(杭州)创新药物研究院揭牌仪式上签约",
    "href": "http://stock.jrj.com.cn/2019/12/27000029852465.shtml",
    "datetime": "2019-12-27 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“所企合力 培养人才·饮水思源 科技报国”",
    "href": "http://stock.jrj.com.cn/2019/12/27000029852458.shtml",
    "datetime": "2019-12-27 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：药品获得许可进入II/III期临床试验",
    "href": "http://stock.jrj.com.cn/2019/12/19170828557647.shtml",
    "datetime": "2019-12-19 17:08:35",
    "code": "600216"
  },
  {
    "title": "浙江医药乳腺癌药物一期临床取得进展 已投入2亿国内尚无同类产品上市",
    "href": "http://stock.jrj.com.cn/2019/12/14001228532437.shtml",
    "datetime": "2019-12-14 00:12:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届九次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/11000028515767.shtml",
    "datetime": "2019-12-11 00:00:04",
    "code": "600216"
  },
  {
    "title": "浙江医药：苹果酸奈诺沙星胶囊新纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28164728463760.shtml",
    "datetime": "2019-11-28 16:47:14",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于首期限制性股票激励计划预留部分授予限制性股票第二个解锁期解锁暨上市的公告",
    "href": "http://stock.jrj.com.cn/2019/11/18233028415121.shtml",
    "datetime": "2019-11-18 23:30:00",
    "code": "600216"
  },
  {
    "title": "维生素概念再度拉升 浙江医药涨停",
    "href": "http://stock.jrj.com.cn/hotstock/2019/11/01102528337296.shtml",
    "datetime": "2019-11-01 10:25:00",
    "code": "600216"
  },
  {
    "title": "浙江医药前三季度盈利3.6亿 同比下滑30%",
    "href": "http://stock.jrj.com.cn/2019/10/23092028286479.shtml",
    "datetime": "2019-10-23 09:20:14",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届八次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2019/10/23011028285022.shtml",
    "datetime": "2019-10-23 01:10:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于首期限制性股票激励计划首次授予限制性股票第三个解锁期解锁暨上市的公告",
    "href": "http://stock.jrj.com.cn/2019/10/23011028285021.shtml",
    "datetime": "2019-10-23 01:10:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/23011028285005.shtml",
    "datetime": "2019-10-23 01:10:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]公司八届七次董事会、八届五次监事会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/08/27000029852467.shtml",
    "datetime": "2019-08-27 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届七次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/22225028019324.shtml",
    "datetime": "2019-08-22 22:50:11",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/22225028019323.shtml",
    "datetime": "2019-08-22 22:50:11",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利2.81亿元 同比下降40%",
    "href": "http://stock.jrj.com.cn/2019/08/22183328018108.shtml",
    "datetime": "2019-08-22 18:33:07",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利同比降40%",
    "href": "http://stock.jrj.com.cn/2019/08/22183328018148.shtml",
    "datetime": "2019-08-22 18:33:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/06/20225027733054.shtml",
    "datetime": "2019-06-20 22:50:03",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药荣膺2019年医药国际化百强企业奖项",
    "href": "http://stock.jrj.com.cn/2019/06/19000027790852.shtml",
    "datetime": "2019-06-19 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/06/06093027670586.shtml",
    "datetime": "2019-06-06 09:30:06",
    "code": "600216"
  },
  {
    "title": "浙江医药证券事务代表巫梦梦辞职",
    "href": "http://stock.jrj.com.cn/2019/06/06074827670146.shtml",
    "datetime": "2019-06-06 07:48:21",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药一项目在中国药科大学(杭州)创新药物研究院揭牌仪式上签约",
    "href": "http://stock.jrj.com.cn/2019/05/10000027588831.shtml",
    "datetime": "2019-05-10 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]关于浙江医药股份有限公司昌海生物分公司年产6500吨三甲基苯醌技改项目环保公示的通知",
    "href": "http://stock.jrj.com.cn/2019/05/06000027528906.shtml",
    "datetime": "2019-05-06 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]关于浙江医药股份有限公司昌海生物分公司维生素E安全环保提升技改项目环保公示的通知",
    "href": "http://stock.jrj.com.cn/2019/05/06000027528907.shtml",
    "datetime": "2019-05-06 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：已累计回购0.71%股份 耗资近6000万元",
    "href": "http://stock.jrj.com.cn/2019/04/30154427514637.shtml",
    "datetime": "2019-04-30 15:44:04",
    "code": "600216"
  },
  {
    "title": "[浙江医药]关于浙江昌海制药有限公司年产80吨去甲基金霉素技改项目环保公示的通知",
    "href": "http://stock.jrj.com.cn/2019/04/26000027495349.shtml",
    "datetime": "2019-04-26 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药2019年第一季度净利1.3亿元 董事长李春波持有公司股份9万股",
    "href": "http://stock.jrj.com.cn/2019/04/24231727478526.shtml",
    "datetime": "2019-04-24 23:17:23",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届六次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/23231027469519.shtml",
    "datetime": "2019-04-23 23:10:08",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/23231027469517.shtml",
    "datetime": "2019-04-23 23:10:08",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/23231027469518.shtml",
    "datetime": "2019-04-23 23:10:08",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/23231027469520.shtml",
    "datetime": "2019-04-23 23:10:08",
    "code": "600216"
  },
  {
    "title": "浙江医药去年净利3.7亿元 同比增长44% 董事长李春波薪酬131万元",
    "href": "http://stock.jrj.com.cn/2019/04/23214227469052.shtml",
    "datetime": "2019-04-23 21:42:38",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年净利同比增44% 一季度业绩同比降逾七成",
    "href": "http://stock.jrj.com.cn/2019/04/23213527468889.shtml",
    "datetime": "2019-04-23 21:35:45",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年净利同比增44% 拟10派1.5元",
    "href": "http://stock.jrj.com.cn/2019/04/23183327467804.shtml",
    "datetime": "2019-04-23 18:33:17",
    "code": "600216"
  },
  {
    "title": "浙江医药：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/23183027467784.shtml",
    "datetime": "2019-04-23 18:30:00",
    "code": "600216"
  },
  {
    "title": "浙江医药将花不超1亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2019/03/24074727216107.shtml",
    "datetime": "2019-03-24 07:47:42",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届五次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2019/03/23000027211141.shtml",
    "datetime": "2019-03-23 00:00:19",
    "code": "600216"
  },
  {
    "title": "浙江医药：回购上限金额上调到1.5亿元",
    "href": "http://stock.jrj.com.cn/2019/03/22165827209053.shtml",
    "datetime": "2019-03-22 16:58:30",
    "code": "600216"
  },
  {
    "title": "[浙江医药]博士后工作再创佳绩",
    "href": "http://stock.jrj.com.cn/2019/02/19000027063192.shtml",
    "datetime": "2019-02-19 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：新昌制药厂通过美国FDA现场检查",
    "href": "http://stock.jrj.com.cn/2019/01/30174827002798.shtml",
    "datetime": "2019-01-30 17:48:31",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂举行2018年度先进表彰大会",
    "href": "http://stock.jrj.com.cn/2019/01/24000026991598.shtml",
    "datetime": "2019-01-24 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂举行2018年度先进表彰大会",
    "href": "http://stock.jrj.com.cn/2019/01/23000029852454.shtml",
    "datetime": "2019-01-23 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“类胡萝卜素的合成新技术”项目通过鉴定",
    "href": "http://stock.jrj.com.cn/2018/12/15000027775483.shtml",
    "datetime": "2018-12-15 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“类胡萝卜素的合成新技术”项目通过鉴定",
    "href": "http://stock.jrj.com.cn/2018/12/15000026821425.shtml",
    "datetime": "2018-12-15 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]公司博士后出站会议在上海交通大学药学院举行",
    "href": "http://stock.jrj.com.cn/2018/12/03000025460515.shtml",
    "datetime": "2018-12-03 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江昌海制药有限公司年产21吨盐酸米诺环素技改项目环评公示公告",
    "href": "http://stock.jrj.com.cn/2018/11/30000025426209.shtml",
    "datetime": "2018-11-30 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]公司荣获首届科促会科学技术奖标准创新组织奖和标准创新项目奖,许新德博士获个人贡献奖",
    "href": "http://stock.jrj.com.cn/2018/11/29000025420985.shtml",
    "datetime": "2018-11-29 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/26220025410824.shtml",
    "datetime": "2018-11-26 22:00:11",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于首期限制性股票激励计划预留部分授予限制性股票第一个解锁期解锁暨上市的公告",
    "href": "http://stock.jrj.com.cn/2018/11/17002025360961.shtml",
    "datetime": "2018-11-17 00:20:34",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟斥资0.5亿至1.5亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/12080025331864.shtml",
    "datetime": "2018-11-12 08:00:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：联合宁波君煜共同设立投资子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/12080025331873.shtml",
    "datetime": "2018-11-12 08:00:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届四次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/10010025326402.shtml",
    "datetime": "2018-11-10 01:00:13",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/11/10010025326403.shtml",
    "datetime": "2018-11-10 01:00:13",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟5000万至1.5亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/11/09155625323672.shtml",
    "datetime": "2018-11-09 15:56:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：十一酸睾酮软胶囊新进入国家基本药物目录",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/29080025270483.shtml",
    "datetime": "2018-10-29 08:00:01",
    "code": "600216"
  },
  {
    "title": "[浙江医药]增强企业科研实力,加快技术创新步伐——浙江医药新增二家院士工作站",
    "href": "http://stock.jrj.com.cn/2018/10/29000025292855.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“名士之乡”人才峰会 我公司喜获多项殊荣",
    "href": "http://stock.jrj.com.cn/2018/10/29000025292856.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：十一酸睾酮新进国家基本药物目录",
    "href": "http://stock.jrj.com.cn/2018/10/26165825264757.shtml",
    "datetime": "2018-10-26 16:58:50",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届三次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/23220025248111.shtml",
    "datetime": "2018-10-23 22:00:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/23220025248109.shtml",
    "datetime": "2018-10-23 22:00:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于首期限制性股票激励计划首次授予限制性股票第二个解锁期解锁暨上市的公告",
    "href": "http://stock.jrj.com.cn/2018/10/23220025248107.shtml",
    "datetime": "2018-10-23 22:00:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/23202025247762.shtml",
    "datetime": "2018-10-23 20:20:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：前三季度净利5.15亿元 同比增近3倍",
    "href": "http://stock.jrj.com.cn/2018/10/23191425247524.shtml",
    "datetime": "2018-10-23 19:14:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]我厂成功举办浙江省“创新药物研发、化学药物关键技术研究”高级研修班",
    "href": "http://stock.jrj.com.cn/2018/10/08000029852450.shtml",
    "datetime": "2018-10-08 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]新昌制药厂成功举办浙江省“创新药物研发、化学药物关键技术研究”高级研修班",
    "href": "http://stock.jrj.com.cn/2018/10/01000025180076.shtml",
    "datetime": "2018-10-01 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利4.69亿元 同比增长420%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/23080024989294.shtml",
    "datetime": "2018-08-23 08:00:03",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/23001024988128.shtml",
    "datetime": "2018-08-23 00:10:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届二次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/23001024988129.shtml",
    "datetime": "2018-08-23 00:10:01",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利4.69亿元 同比增长近4.2倍",
    "href": "http://stock.jrj.com.cn/2018/08/22162024986560.shtml",
    "datetime": "2018-08-22 16:20:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利4.69亿元 同比增420%",
    "href": "http://stock.jrj.com.cn/2018/08/22160024986429.shtml",
    "datetime": "2018-08-22 16:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/22160024986388.shtml",
    "datetime": "2018-08-22 16:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利同比增长419.86%",
    "href": "http://stock.jrj.com.cn/2018/08/22155224986366.shtml",
    "datetime": "2018-08-22 15:52:05",
    "code": "600216"
  },
  {
    "title": "[互动]浙江医药：公司没有生产人类疫苗产品",
    "href": "http://stock.jrj.com.cn/2018/07/23153724851081.shtml",
    "datetime": "2018-07-23 15:37:13",
    "code": "600216"
  },
  {
    "title": "浙江医药：公司没有生产人类疫苗产品",
    "href": "http://stock.jrj.com.cn/2018/07/23113024849685.shtml",
    "datetime": "2018-07-23 11:30:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江昌海制药有限公司年产2.4吨奈诺沙星侧链(MAP)、年产50吨磷酯酰丝氨酸(PS)项目环评公示",
    "href": "http://stock.jrj.com.cn/2018/07/19000024838122.shtml",
    "datetime": "2018-07-19 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/07/11213024801568.shtml",
    "datetime": "2018-07-11 21:30:03",
    "code": "600216"
  },
  {
    "title": "浙江医药股东提前终止减持计划",
    "href": "http://stock.jrj.com.cn/2018/07/11165824800546.shtml",
    "datetime": "2018-07-11 16:58:47",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药股份有限公司昌海生物分公司VA和VD3项目环境保护设施竣工(先行)验收监测报告",
    "href": "http://stock.jrj.com.cn/2018/07/11000024829037.shtml",
    "datetime": "2018-07-11 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药股份有限公司昌海生物分公司二期项目(β-胡萝卜素)环境保护设施竣工(先行)验收监测报告",
    "href": "http://stock.jrj.com.cn/2018/07/11000024829039.shtml",
    "datetime": "2018-07-11 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江昌海制药有限公司达托霉素项目环境保护设施竣工(先行)验收监测报告",
    "href": "http://stock.jrj.com.cn/2018/07/11000024829038.shtml",
    "datetime": "2018-07-11 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药入围中国医药行业双百强",
    "href": "http://stock.jrj.com.cn/2018/06/28000024826441.shtml",
    "datetime": "2018-06-28 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：第八届一次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2018/06/15215024687895.shtml",
    "datetime": "2018-06-15 21:50:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/06/15215024687894.shtml",
    "datetime": "2018-06-15 21:50:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]“高效脂肪酶催化制备脂溶性维生素关键技术及产业化”项目通过技术鉴定",
    "href": "http://stock.jrj.com.cn/2018/06/01000027010488.shtml",
    "datetime": "2018-06-01 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：维生素E5月份市场价格下降",
    "href": "http://stock.jrj.com.cn/2018/05/28134324599223.shtml",
    "datetime": "2018-05-28 13:43:40",
    "code": "600216"
  },
  {
    "title": "浙江医药：5月份维生素E市场价格明显下降",
    "href": "http://stock.jrj.com.cn/2018/05/28131024599108.shtml",
    "datetime": "2018-05-28 13:10:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：抗HER2-ADC项目正在进行一期临床研究",
    "href": "http://stock.jrj.com.cn/2018/05/28123024599037.shtml",
    "datetime": "2018-05-28 12:30:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：第七届十九次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2018/05/24222024587556.shtml",
    "datetime": "2018-05-24 22:20:08",
    "code": "600216"
  },
  {
    "title": "浙江医药：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/05/24222024587557.shtml",
    "datetime": "2018-05-24 22:20:08",
    "code": "600216"
  },
  {
    "title": "[浙江医药]国投高新潘勇董事长实地考察昌海产业园",
    "href": "http://stock.jrj.com.cn/2018/05/14000024540849.shtml",
    "datetime": "2018-05-14 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2017年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443678.shtml",
    "datetime": "2018-04-25 00:30:07",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443679.shtml",
    "datetime": "2018-04-25 00:30:07",
    "code": "600216"
  },
  {
    "title": "浙江医药：第七届十八次董事会决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443680.shtml",
    "datetime": "2018-04-25 00:30:07",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/24182024442215.shtml",
    "datetime": "2018-04-24 18:20:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]公司第七届十八次董事会及第七届十五次监事会在昌海召开",
    "href": "http://stock.jrj.com.cn/2018/04/24000024464545.shtml",
    "datetime": "2018-04-24 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江昌海制药有限公司年产500吨药用级VE等技改项目公示公告",
    "href": "http://stock.jrj.com.cn/2018/04/13000024394559.shtml",
    "datetime": "2018-04-13 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年第一季度业绩预增公告",
    "href": "http://stock.jrj.com.cn/2018/03/13082024231415.shtml",
    "datetime": "2018-03-13 08:20:03",
    "code": "600216"
  },
  {
    "title": "浙江医药一季报预增逾18倍 因维生素涨价",
    "href": "http://stock.jrj.com.cn/2018/03/12191224228668.shtml",
    "datetime": "2018-03-12 19:12:07",
    "code": "600216"
  },
  {
    "title": "浙江医药：维生素大幅涨价 一季度净利预增逾18倍",
    "href": "http://stock.jrj.com.cn/2018/03/12184024228537.shtml",
    "datetime": "2018-03-12 18:40:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/03/12184024228521.shtml",
    "datetime": "2018-03-12 18:40:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]辅酶Q10产品诉讼案结案——浙江医药胜诉",
    "href": "http://stock.jrj.com.cn/2018/01/23000024014263.shtml",
    "datetime": "2018-01-23 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]博士后出站会议在杭州举行",
    "href": "http://stock.jrj.com.cn/2017/12/29000023873579.shtml",
    "datetime": "2017-12-29 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]公司2018年度经营工作会议在新昌召开",
    "href": "http://stock.jrj.com.cn/2017/12/11000023967647.shtml",
    "datetime": "2017-12-11 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：公司维生素A正常生产 不受巴斯夫火灾影响",
    "href": "http://stock.jrj.com.cn/2017/11/28100523705644.shtml",
    "datetime": "2017-11-28 10:05:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]第四届“来益杯”优秀论文评选活动圆满举办",
    "href": "http://stock.jrj.com.cn/2017/11/27000023756225.shtml",
    "datetime": "2017-11-27 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]全国总工会副主席阎京华调研昌海生物",
    "href": "http://stock.jrj.com.cn/2017/11/17000023707329.shtml",
    "datetime": "2017-11-17 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：2017年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2017/10/22183023267145.shtml",
    "datetime": "2017-10-22 18:30:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：前三季净利同比下降67.55%",
    "href": "http://stock.jrj.com.cn/2017/10/22145023266889.shtml",
    "datetime": "2017-10-22 14:50:00",
    "code": "600216"
  },
  {
    "title": "浙江医药年报推10派1.45元 股权登记7月18日",
    "href": "http://stock.jrj.com.cn/2017/07/11184722733648.shtml",
    "datetime": "2017-07-11 18:47:04",
    "code": "600216"
  },
  {
    "title": "浙江医药:打造中国医药“百年老店”",
    "href": "http://stock.jrj.com.cn/2017/05/17203322494187.shtml",
    "datetime": "2017-05-17 20:33:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]浙江医药二十周年庆 打造中国医药“百年老店”",
    "href": "http://stock.jrj.com.cn/2017/05/17000022959218.shtml",
    "datetime": "2017-05-17 00:00:00",
    "code": "600216"
  },
  {
    "title": "[浙江医药]昌海生物分公司顺利完成GMP+饲料认证体系换证工作",
    "href": "http://stock.jrj.com.cn/2017/04/21000022959217.shtml",
    "datetime": "2017-04-21 00:00:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：拟吸收合并全资子公司并设立分公司",
    "href": "http://stock.jrj.com.cn/hotstock/2014/09/15080018005283.shtml",
    "datetime": "2014-09-15 08:00:16",
    "code": "600216"
  },
  {
    "title": "浙江医药Q1净利跌48% 公司称维E降价是主因",
    "href": "http://stock.jrj.com.cn/2014/04/29045217125801.shtml",
    "datetime": "2014-04-29 04:52:55",
    "code": "600216"
  },
  {
    "title": "业绩不佳放利好 浙江医药为解禁股开道？",
    "href": "http://stock.jrj.com.cn/2013/09/26022515889938.shtml",
    "datetime": "2013-09-26 02:25:36",
    "code": "600216"
  },
  {
    "title": "浙江医药年产2万吨高含量维生素E项目试生产",
    "href": "http://stock.jrj.com.cn/invest/2013/09/25182415888923.shtml",
    "datetime": "2013-09-25 18:24:00",
    "code": "600216"
  },
  {
    "title": "维E价格下跌 浙江医药中期净利同比降34%",
    "href": "http://stock.jrj.com.cn/2013/08/09162715660613.shtml",
    "datetime": "2013-08-09 16:27:02",
    "code": "600216"
  },
  {
    "title": "浙江医药与AMBRX公司合作开发乳腺癌药物",
    "href": "http://stock.jrj.com.cn/2013/06/17163415408523.shtml",
    "datetime": "2013-06-17 16:34:10",
    "code": "600216"
  },
  {
    "title": "获AMBRX公司授权 浙江医药将开发乳腺癌治疗药物",
    "href": "http://stock.jrj.com.cn/2013/06/17005815404744.shtml",
    "datetime": "2013-06-17 00:58:00",
    "code": "600216"
  },
  {
    "title": "浙江医药2012年净利降16% 拟10派5",
    "href": "http://stock.jrj.com.cn/2013/04/12175215223764.shtml",
    "datetime": "2013-04-12 17:52:24",
    "code": "600216"
  },
  {
    "title": "禽流感袭击美国 近亿资金涌入3只概念股",
    "href": "http://stock.jrj.com.cn/hotstock/2013/02/19062115064281.shtml",
    "datetime": "2013-02-19 06:21:52",
    "code": "600216"
  },
  {
    "title": "弱市中基金力捧浙江医药东北证券定增",
    "href": "http://stock.jrj.com.cn/hotstock/2012/09/03045114336027.shtml",
    "datetime": "2012-09-03 04:51:13",
    "code": "600216"
  },
  {
    "title": "浙江医药:医药制造产品是上半年经营亮点",
    "href": "http://stock.jrj.com.cn/hotstock/2012/08/30124914312844.shtml",
    "datetime": "2012-08-30 12:49:09",
    "code": "600216"
  },
  {
    "title": "浙江两大上市维E巨头受成本推动相继提价",
    "href": "http://stock.jrj.com.cn/2012/08/28140714287991.shtml",
    "datetime": "2012-08-28 14:07:30",
    "code": "600216"
  },
  {
    "title": "高抛低吸 两基金3.6亿热捧浙江医药定增",
    "href": "http://stock.jrj.com.cn/2012/08/28081014282323.shtml",
    "datetime": "2012-08-28 08:10:16",
    "code": "600216"
  },
  {
    "title": "浙江医药拟购奈诺沙星专利",
    "href": "http://stock.jrj.com.cn/2012/06/01001913333813.shtml",
    "datetime": "2012-06-01 00:19:40",
    "code": "600216"
  },
  {
    "title": "浙江医药2011年净利降11% 拟10派6元",
    "href": "http://stock.jrj.com.cn/2012/04/23184612874402.shtml",
    "datetime": "2012-04-23 18:46:56",
    "code": "600216"
  },
  {
    "title": "浙江医药上半年实现净利润5.95亿",
    "href": "http://stock.jrj.com.cn/2011/08/24191010841477.shtml",
    "datetime": "2011-08-24 19:10:10",
    "code": "600216"
  },
  {
    "title": "检修潮已到 浙江医药维生素厂停产",
    "href": "http://stock.jrj.com.cn/2011/07/22151610517101.shtml",
    "datetime": "2011-07-22 15:16:56",
    "code": "600216"
  },
  {
    "title": "浙江医药主要生产企业停产检修",
    "href": "http://stock.jrj.com.cn/2011/07/21202710507668.shtml",
    "datetime": "2011-07-21 20:27:00",
    "code": "600216"
  },
  {
    "title": "浙江医药涉诉信披迟到3个月 或为掩护股东高价套现",
    "href": "http://stock.jrj.com.cn/2011/07/11073410406157.shtml",
    "datetime": "2011-07-11 07:34:08",
    "code": "600216"
  },
  {
    "title": "浙江医药：产业升级的低估值企业 买入",
    "href": "http://stock.jrj.com.cn/hotstock/2011/07/09005110402004.shtml",
    "datetime": "2011-07-09 00:51:55",
    "code": "600216"
  },
  {
    "title": "浙江医药拟定增募资20亿扩产",
    "href": "http://stock.jrj.com.cn/2011/07/04103110353834.shtml",
    "datetime": "2011-07-04 10:31:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：停牌筹划定向增发",
    "href": "http://stock.jrj.com.cn/2011/06/27094410300237.shtml",
    "datetime": "2011-06-27 09:44:30",
    "code": "600216"
  },
  {
    "title": "浙江医药：上半年净利增长88%",
    "href": "http://stock.jrj.com.cn/2010/08/2410198011128.shtml",
    "datetime": "2010-08-24 10:19:32",
    "code": "600216"
  },
  {
    "title": "浙江医药：目标价为46.35元 买入评级",
    "href": "http://stock.jrj.com.cn/hotstock/2010/04/1916057318083.shtml",
    "datetime": "2010-04-19 16:05:00",
    "code": "600216"
  },
  {
    "title": "浙江医药：估值偏低 审慎推荐评级",
    "href": "http://stock.jrj.com.cn/hotstock/2010/01/2107376845036.shtml",
    "datetime": "2010-01-21 07:37:06",
    "code": "600216"
  },
  {
    "title": "浙江医药：震荡攀升创历史新高 买入",
    "href": "http://stock.jrj.com.cn/hotstock/2010/01/1407566804034.shtml",
    "datetime": "2010-01-14 07:56:03",
    "code": "600216"
  },
  {
    "title": "浙江医药：瞄准南美抗疟原料药市场",
    "href": "http://stock.jrj.com.cn/2010/01/0707236763318.shtml",
    "datetime": "2010-01-07 07:23:02",
    "code": "600216"
  }
]